semaglutide weight loss diabetes FDA approves obesity drug that helped people cut 15% Ozempic® GLP for Weight Loss

Projections indicate that annual deaths from melanoma will rise to approximately 2,800 by 20382040, despite a projected 12% decrease in mortality rates

GLP-1 receptor agonists are revolutionizing the treatment of type 2 diabetes and obesity

Obesity is not just a hypertrophy of the adipose tissue because it may become dysfunctional and inflamed resulting in increased insulin resistance

These changes often occur due to rapid fat and in some cases, muscle loss, which can leave skin looking more loose and aged, particularly on the face and buttocks

The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth